Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris

NCT01743118 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: SPS4251 Ointment
DRUG: Placebo
DRUG: Daivonex® ointment

Sponsor

Circassia Limited

Collaborators

[object Object]